sickle cell anemia: has quality advantage

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents red blood cell
Weight: 0.74
, disease
Weight: 0.72
, anemia
Weight: 0.70
, condition
Weight: 0.68
Siblings lyme disease
Weight: 0.37
, pelvic inflammatory disease
Weight: 0.37
, thalassemia
Weight: 0.36
, polycythemia
Weight: 0.36
, macular degeneration
Weight: 0.35

Related properties

Property Similarity
has quality advantage 1.00
be good example of heterozygote advantage 0.85
be example of heterozygote advantage 0.84

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.46
Plausible(sickle cell anemia, has quality advantage)
Evidence: 0.32
¬ Salient(sickle cell anemia, has quality advantage)

Similarity expansion

0.55
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.84
Evidence: 0.70
Typical(sickle cell anemia, has quality advantage)
Evidence: 0.73
¬ Typical(sickle cell anemia, be example of heterozygote advantage)
0.54
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.85
Evidence: 0.70
Typical(sickle cell anemia, has quality advantage)
Evidence: 0.83
¬ Typical(sickle cell anemia, be good example of heterozygote advantage)
0.48
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.85
Evidence: 0.23
Remarkable(sickle cell anemia, has quality advantage)
Evidence: 0.44
¬ Remarkable(sickle cell anemia, be good example of heterozygote advantage)
0.43
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.85
Evidence: 0.46
Plausible(sickle cell anemia, has quality advantage)
Evidence: 0.74
¬ Plausible(sickle cell anemia, be good example of heterozygote advantage)
0.38
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.84
Evidence: 0.23
Remarkable(sickle cell anemia, has quality advantage)
Evidence: 0.60
¬ Remarkable(sickle cell anemia, be example of heterozygote advantage)
0.37
Rule weight: 0.85
Evidence weight: 0.51
Similarity weight: 0.85
Evidence: 0.32
Salient(sickle cell anemia, has quality advantage)
Evidence: 0.71
¬ Salient(sickle cell anemia, be good example of heterozygote advantage)
0.34
Rule weight: 0.85
Evidence weight: 0.47
Similarity weight: 0.84
Evidence: 0.46
Plausible(sickle cell anemia, has quality advantage)
Evidence: 0.97
¬ Plausible(sickle cell anemia, be example of heterozygote advantage)
0.31
Rule weight: 0.85
Evidence weight: 0.43
Similarity weight: 0.84
Evidence: 0.32
Salient(sickle cell anemia, has quality advantage)
Evidence: 0.83
¬ Salient(sickle cell anemia, be example of heterozygote advantage)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.32
Salient(sickle cell anemia, has quality advantage)
Evidence: 0.70
¬ Typical(sickle cell anemia, has quality advantage)
Evidence: 0.23
¬ Remarkable(sickle cell anemia, has quality advantage)

Typical implies Plausible

0.30
Rule weight: 0.48
Evidence weight: 0.62
Similarity weight: 1.00
Evidence: 0.46
Plausible(sickle cell anemia, has quality advantage)
Evidence: 0.70
¬ Typical(sickle cell anemia, has quality advantage)